Список литературы

Поставить закладку

Адамян Л. В. Состояние репродуктивной системы у больных доброкачественными опухолями внутренних гениталий и принципы восстановительного лечения //Москва. – 1985. Москва.
El-Balat A. et al. Modern Myoma Treatment in the Last 20 Years: A Review of the Literature //BioMed research international. – 2018. – Т. 2018.
Pérez-López F. R. et al. EMAS position statement: management of uterine ﬁbroids //Maturitas. – 2014. – Т. 79. – №. 1. – С. 106-116.
Kubik-Huch R. A. et al. European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of leiomyomas //European radiology. – 2018. – Т. 28. – №. 8. – С. 3125-3137.
Grings A. O. et al. Protein expression of estrogen receptors α and β and aromatase in myometrium and uterine leiomyoma //Gynecologic and obstetric investigation. – 2012. – Т. 73. – №. 2. – С. 113-117.
Markowski D. N. et al. HMGA2 and p14Arf: major roles in cellular senescence of ﬁbroids and therapeutic implications //Anticancer research. – 2011. – Т. 31. – №. 3. – С. 753-761.
Ciavattini A. et al. Uterine ﬁbroids: pathogenesis and interactions with endometrium and endomyometrial junction //Obstetrics and gynecology international. – 2013. – Т. 2013.
Mittal P. et al. Med12 gain-of-function mutation causes leiomyomas and genomic instability //The Journal of clinical investigation. – 2015. – Т. 125. – №. 8. – С. 3280-3284.
Osinovskaya N. S. et al. Frequency and spectrum of MED12 exon 2 mutations in multiple versus solitary uterine leiomyomas from Russian patients //International journal of gynecological pathology. – 2016. – Т. 35. – №. 6. – С. 509-515.
Tal R., Segars J. H. The role of angiogenic factors in ﬁbroid pathogenesis: potential implications for future therapy //Human reproduction update. – 2013. – Т. 20. – №. 2. – С. 194-216.
Сидорова И. С. и др. Современное состояние вопроса о патогенезе, клинике, диагностике и лечении миомы матки у женщин репродуктивного возраста //Акушерство, гинекология и репродукция. – 2012. – Т. 6. – №. 4.
Ren Y. et al. Different effects of epidermal growth factor on smooth muscle cells derived from human myometrium and from leiomyoma //Fertility and sterility. – 2011. – Т. 96. – №. 4. – С. 1015- 1020.
Plewka D. et al. Expression of VEGF isoforms and their receptors in uterine myomas //Ginekologia polska. – 2016. – Т. 87. – №. 3. – С. 166-177.
Baird D. D. et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence //American journal of obstetrics and gynecology. – 2003. – Т. 188. – №. 1. – С. 100-107.
Chiaffarino F. et al. Alcohol consumption and risk of uterine myoma: A systematic review and meta analysis //PloS one. – 2017. – Т. 12. – №. 11. – С. e0188355.
Серов В. Н., Сухих Г. Т. Клинические рекомендации. Акушерство и гинекология //М: ГЭОТАР-Медиа.-4-е изд.-2017. Москва: Проблемы репродукции.
Donnez J., Donnez O., Dolmans M. M. With the advent of selective progesterone receptor modulators, what is the place of myoma surgery in current practice? //Fertility and Sterility. – 2014. – Т. 102. – №. 3. – С. 640-648.
Worldwide A. A. M. I. G. AAGL practice report: practice guidelines for the management of hysteroscopic distending media:(replaces hysteroscopic ﬂuid monitoring guidelines. J Am Assoc Gynecol Laparosc. 2000; 7: 167–168.) //Journal of minimally invasive gynecology. – 2013. – Т. 20. – №. 2. – С. 137-148.
SOGC clinical practice guideline, The Management of Uterine Leiomyomas, No. 318.
Stewart E. A. et al. Epidemiology of uterine ﬁbroids: a systematic review //BJOG: An International Journal of Obstetrics & Gynaecology. – 2017. – Т. 124. – №. 10. – С. 1501-1512.
Zepiridis L. I., Grimbizis G. F., Tarlatzis B. C. Infertility and uterine ﬁbroids //Best Practice & Research Clinical Obstetrics & Gynaecology. – 2016. – Т. 34. – С. 66-73.
Parazzini F., Tozzi L., Bianchi S. Pregnancy outcome and uterine ﬁbroids //Best practice & research Clinical obstetrics & gynaecology. – 2016. – Т. 34. – С. 74-84.
Munro M. G. et al. FIGO classiﬁcation system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age //International Journal of Gynecology & Obstetrics. – 2011. – Т. 113. – №. 1. – С. 3-13.
Munro M. G. et al. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classiﬁcation of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions //International Journal of Gynecology & Obstetrics. – 2018.
Suzuki A. et al. Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma Using Magnetic Resonance Images: A Literature Review //Healthcare. – Multidisciplinary Digital Publishing Institute, 2019. – Т. 7. – №. 4. – С. 158.
Савельева Г. М. и др. Национальное руководство //Акушерство–М.: Гэотар-Медиа. – 2015.
Marret H. et al. Therapeutic management of uterine ﬁbroid tumors: updated French guidelines //European Journal of Obstetrics & Gynecology and Reproductive Biology. – 2012. – Т. 165. – №. 2. – С. 156-164.
Fascilla F. D. et al. Ultrasound diagnosis of uterine myomas //Minerva ginecologica. – 2016. – Т. 68. – №. 3. – С. 297-312.
Minsart A. F. et al. Does three‐dimensional power Doppler ultrasound predict histopathological ﬁndings of uterine ﬁbroids? A preliminary study //Ultrasound in obstetrics & gynecology. – 2012. – Т. 40. – №. 6. – С. 714-720.
Levine D. J. et al. Sensitivity of myoma imaging using laparoscopic ultrasound compared with magnetic resonance imaging and transvaginal ultrasound //Journal of minimally invasive gynecology. – 2013. – Т. 20. – №. 6. – С. 770-774.
Yang T. et al. Sonohysterography: Principles, technique and role in diagnosis of endometrial pathology //World journal of radiology. – 2013. – Т. 5. – №. 3. – С. 81.
Woźniak A., Woźniak S. Ultrasonography of uterine leiomyomas //Przeglad menopauzalny= Menopause review. – 2017. – Т. 16. – №. 4. – С. 113.
Dueholm M. et al. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas //American journal of obstetrics and gynecology. – 2002. – Т. 186. – №. 3. – С. 409-415.
De La Cruz M. S., Buchanan E. M. Uterine ﬁbroids: diagnosis and treatment //Am Fam Physician. – 2017. – Т. 95. – №. 2. – С. 100-107.
Donnez J., Dolmans M. M. Uterine ﬁbroid management: from the present to the future //Human Reproduction Update. – 2016. – Т. 22. – №. 6. – С. 665-686.
Серов В. Н., Сухих Г. Т. Клинические рекомендации. Акушерство и гинекология //М: ГЭОТАР-Медиа.-4-е изд.-2014.-1024C. – 2014. Москва: Проблемы репродукции.
Qin J. et al. Oral contraceptive use and uterine leiomyoma risk: a meta-analysis based on cohort and case–control studies //Archives of gynecology and obstetrics. – 2013. – Т. 288. – №. 1. – С. 139-148.
Roberts M. E., Aynardi J. T., Chu C. S. Uterine leiomyosarcoma: A review of the literature and update on management options //Gynecologic oncology. – 2018.
Eder S. et al. Efﬁcacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and ﬁbroids //Women’s health. – 2013. – Т. 9. – №. 4. – С. 397-403.
Bitzer J. et al. Medical management of heavy menstrual bleeding: a comprehensive review of the literature //Obstetrical & gynecological survey. – 2015. – Т. 70. – №. 2. – С. 115-130.
Lukes A. S. et al. Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial //Obstetrics & Gynecology. – 2010. – Т. 116. – №. 4. – С. 865-875.
Lethaby A., Duckitt K., Farquhar C. Non‐steroidal anti‐inﬂammatory drugs for heavy menstrual bleeding //Cochrane database of systematic reviews. – 2013. – №. 1.
Ichigo S. et al. Beneﬁcial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist //Archives of gynecology and obstetrics. – 2011. – Т. 284. – №. 3. – С. 667-670.
Lethaby A. et al. Progesterone or progestogen‐releasing intrauterine systems for heavy menstrual bleeding //Cochrane Database of Systematic Reviews. – 2015. – №. 4.
Boﬁll M. R. et al. Cyclical progestogens for heavy menstrual bleeding //The Cochrane database of systematic reviews. – 2019. – Т. 8.
Lethaby A., Puscasiu L., Vollenhoven B. Preoperative medical therapy before surgery for uterine ﬁbroids //Cochrane Database of Systematic Reviews. – 2017. – №. 11.
Mas A. et al. Updated approaches for management of uterine ﬁbroids //International journal of women’s health. – 2017. – Т. 9. – С. 607.
Zhang Y. et al. The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine ﬁbroids: a meta-analysis //Obstetrical & gynecological survey. – 2014. – Т. 69. – №. 2. – С. 100-108.
Tristan M. et al. Mifepristone for uterine ﬁbroids //Cochrane Database of Systematic Reviews. – 2012. – №. 8.
Shen Q. et al. Effects of mifepristone on uterine leiomyoma in premenopausal women: a meta-analysis //Fertility and sterility. – 2013. – Т. 100. – №. 6. – С. 1722-1726.
Feng C., Meldrum S., Fiscella K. Improved quality of life is partly explained by fewer symptoms after treatment of ﬁbroids with mifepristone //International Journal of Gynecology & Obstetrics. – 2010. – Т. 109. – №. 2. – С. 121-124., doi: 10.1016/j.ijgo.2009.11.019.
Eisinger S. H. et al. Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata //European Journal of Obstetrics & Gynecology and Reproductive Biology. – 2009. – Т. 146. – №. 2. – С. 215-218.
Chittawar P. B. et al. Minimally invasive surgical techniques versus open myomectomy for uterine ﬁbroids //Cochrane Database of Systematic Reviews. – 2014. – №. 10.
Sandberg E. M. et al. Reintervention risk and quality of life outcomes after uterine-sparing interventions for ﬁbroids: a systematic review and meta-analysis //Fertility and sterility. – 2018. – Т. 109. – №. 4. – С. 698-707.
Kongnyuy E. J., Wiysonge C. S. Interventions to reduce haemorrhage during myomectomy for ﬁbroids //Cochrane Database of Systematic Reviews. – 2014. – №. 8. John Wiley & Sons, Ltd.
ACOG. Leiomyomas P. Uterine Morcellation for Presumed Leiomyomas. – 2019.
Gkrozou F. et al. Hysteroscopy in women with abnormal uterine bleeding: a meta-analysis on four major endometrial pathologies //Archives of gynecology and obstetrics. – 2015. – Т. 291. – №. 6. – С. 1347-1354.
Yin X. et al. Hysteroscopic tissue removal systems for the treatment of intrauterine pathology: a systematic review and meta-analysis //Facts, views & vision in ObGyn. – 2018. – Т. 10. – №. 4. – С. 207.
Sesti F. et al. Randomized comparison of total laparoscopic, laparoscopically assisted vaginal and vaginal hysterectomies for myomatous uteri //Archives of gynecology and obstetrics. – 2014. – Т. 290. – №. 3. – С. 485-491.
Fonseca M. C. M. et al. Uterine artery embolization and surgical methods for the treatment of symptomatic uterine leiomyomas: a systemic review and meta-analysis followed by indirect treatment comparison //Clinical therapeutics. – 2017. – Т. 39. – №. 7.
Gupta J. K. et al. Uterine artery embolization for symptomatic uterine ﬁbroids //Cochrane Database of Systematic Reviews. – 2014. – №. 12. John Wiley & Sons, Ltd.
Czuczwar P. et al. Comparison of the inﬂuence of three ﬁbroid treatment options: Supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve– an observational study //Journal of ovarian research. – 2018. – Т. 11.
Quinn S. D. et al. Safety and ﬁve-year re-intervention following magnetic resonance-guided focused ultrasound (MRgFUS) for uterine ﬁbroids //European Journal of Obstetrics & Gynecology and Reproductive Biology. – 2014. – Т. 182. – С. 247-251., vol. 182.
Rabinovici J. et al. Pregnancy outcome after magnetic resonance–guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine ﬁbroids //Fertility and sterility. – 2010. – Т. 93. – №. 1. – С. 199-209.
Carranza-Mamane B. et al. The management of uterine ﬁbroids in women with otherwise unexplained infertility //Journal of Obstetrics and Gynaecology Canada. – 2015. – Т. 37. – №. 3. – С. 277-285.
Sagi-Dain L. et al. Pregnancy outcomes in oocyte recipients with ﬁbroids not impinging uterine cavity //Archives of gynecology and obstetrics. – 2017. – Т. 295. – №. 2. – С. 497-502.
Wang X. et al. The impact of noncavity-distorting intramural ﬁbroids on the efﬁcacy of in vitro fertilization-embryo transfer: an updated meta-analysis //BioMed research international. – 2018. – Т. 2018.
Radosa M. P. et al. Laparoscopic myomectomy in peri-and post-menopausal women is safe, efﬁcacious and associated with long-term patient satisfaction //European Journal of Obstetrics & Gynecology and Reproductive Biology. – 2012. – Т. 162. – №. 2. – С. 19.
Ulin M. et al. Uterine ﬁbroids in menopause and perimenopause //Menopause. – 2019.
Lethaby A. E., Vollenhoven B. J. An evidence-based approach to hormonal therapies for premenopausal women with ﬁbroids //Best Practice & Research Clinical Obstetrics & Gynaecology. – 2008. – Т. 22. – №. 2. – С. 307-331.
Kaganov H., Ades A., Fraser D. S. Preoperative magnetic resonance imaging diagnostic features of uterine leiomyosarcomas: a systematic review //International journal of technology assessment in health care. – 2018. – Т. 34. – №. 2. – С. 172-179.
Ludovisi M. et al. Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma //Ultrasound in Obstetrics & Gynecology. – 2019. – Т. 54. – №. 5. – С. 676-687.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница